Chanelle McCoy Health Claims First Positive EFSA Opinion on CBD Novel Food Application
The CBD manufacturer has received a draft positive scientific opinion from EFSA on its Novel Food application.
24 results for “toxicology”
The CBD manufacturer has received a draft positive scientific opinion from EFSA on its Novel Food application.
The UK’s long-running project to regulate CBD (cannabidiol) products has taken another major step forward, seeing thousands of products make it to the final phase of the novel foods approval […]
The UK’s Food Standards Agency (FSA) has announced some significant updates to its multi-year CBD Novel Foods approvals process.
A class action alleges that Aurora ‘negligently failed’ to warn consumers of the risk of developing CHS posed by the regular use of its products.
The findings offer some of the first insights into the prevalence of CBD use among adolescents.
Cristelle Santos, consultant toxicologist at Broughton Group, shares her experiences as a toxicologist in the CBD sector.
Libby Clarke, managing consultant for Toxicology at Broughton, explores how CBD companies can optimise their testing strategies.
The decision is expected to remove ‘ambiguity’ around the legal levels of THC and other controlled substances in consumer CBD products.
The change is due to new ‘scientific evidence’ from toxicological studies submitted as part of Novel Food applications.
Earlier this month the government published proposals for sweeping reforms aimed at streamlining access.
Oxford Cannabinoid Technologies is expanding its research and development into oncology.
The company that makes 13% of all CBD food supplements permitted to sell in the UK, are now one step closer to validation and full authorisation British Cannabis, registered as […]
Following new recommendations, is France taking the first tentative steps towards cannabis reform?
A 20-year US study shows alcohol abuse is declining while the consumption of cannabis edibles is on the rise.
Selected cannabinoid and terpenes have the potential to reduce inflammation associated with a range of health conditions.
Synthetic cannabinoids appear to have less appeal in states which have legalised natural cannabis.
Tolerance can be a problem for regular cannabis consumers, but there are a few ways you can manage it.
The firm now manufactures over 12% of all CBD supplements legal to sell in the UK
CBN, CBC and CBDa are just some of the cannabinoids with huge potential for our health and wellbeing.
Anecdotal evidence and a growing body of scientific research indicates that cannabis could be effective in treating fibromyalgia.
Over 300 British Cannabis™ products have passed to the next stage of the UK Novel Foods process
Two experts on how to understand the limitations of cannabis studies.
Research found no relationship between blood THC concentrations and driving performance.
The Sativa Learning course includes insight from doctors and patients